Common diabetes drug tested to stop leukemia from coming back
NCT ID NCT07188740
Summary
This study is testing if metformin, a common diabetes medication, can reduce the level of a specific genetic mutation found in some patients with acute leukemia who are currently in remission. The goal is to see if lowering this mutation can help prevent the cancer from returning. About 30 patients will take metformin pills daily for six months while doctors monitor their blood for changes in the mutation and track their health.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DNMT3A GENE MUTATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.